![]() GammaDelta Therapeutics GammaDelta Therapeutics is a company committed to transforming the treatment of patients living with hematological and solid cancers. | Kuur Therapeutics Kuur Therapeutics (formerly known as Cell Medica) is a company that develops CAR-NKT cell therapy to treat cancer. | ![]() Ossium Health Ossium Health is a company building bone marrow bank to treat blood cancers, improve organ transplantation, and repair damage from radiation. | ![]() immunoSCAPE immunoSCAPE is a company that measures treatment and outcome-associated changes in antigen-specific T cells and patient immune response. | PrimeVax Immuno-Oncology PrimeVax Immuno-Oncology is a company that develops a multi-mechanism treatment for cancer, leveraging whole body systemic fever along with personalized neo-antigens. | |
Founding Date | Founding Date 2016 | Founding Date 2020 | Founding Date 2016 | Founding Date 2016 | Founding Date 2015 |
Type | Type Subsidiary | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations London, GB HQ | Locations London, GB HQ | Locations San Francisco, US HQ Indianapolis, US | Locations Singapore, SG HQ Nucleos, SG Cambridge, US San Diego, US | Locations Orange, US HQ |
Employees | Employees 5 | Employees 9 | Employees 89 | Employees 329% decrease | Employees 7 |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 63m (about 5 years ago) | Latest funding round $ 14m (about 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 73.4m | Total funding raised $ 24.9m | Total funding raised N/A |
Kuur Therapeutics (formerly known as Cell Medica) is a company that develops CAR-NKT cell therapy to treat cancer.
View company
Ossium Health is a company building bone marrow bank to treat blood cancers, improve organ transplantation, and repair damage from radiation.
View company
immunoSCAPE is a company that measures treatment and outcome-associated changes in antigen-specific T cells and patient immune response.
View companyPrimeVax Immuno-Oncology is a company that develops a multi-mechanism treatment for cancer, leveraging whole body systemic fever along with personalized neo-antigens.
View company